Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses.
Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses.
复制标题
DOI:
10.1007/s11481-021-10028-1
复制
发表时间:
2021-12
期刊:
影响因子:
--
通讯作者:
Pahan K
中科院分区:
文献类型:
--
作者:
Paidi RK;Jana M;Raha S;McKay M;Sheinin M;Mishra RK;Pahan K
Spike S1 of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) binds to angiotensin-converting enzyme 2 (ACE2) on host cells to enter the cell and initiate COVID-19. Since ACE2 is a favorable enzyme, we were interested in finding a molecule capable of binding spike S1, but not ACE2, and inhibiting the interaction between spike S1 and ACE2. Holy basil (Tulsi) has a long history as a medicine for different human disorders. Therefore, we screened different components of Tulsi leaf and found that eugenol, but not other major components (e.g. ursolic acid, oleanolic acid and β-caryophylline), inhibited the interaction between spike S1 and ACE2 in an AlphaScreen-based assay. By in silico analysis and thermal shift assay, we also observed that eugenol associated with spike S1, but not ACE2. Accordingly, eugenol strongly suppressed the entry of pseudotyped SARS-CoV-2, but not vesicular stomatitis virus (VSV), into human ACE2-expressing HEK293 cells. Eugenol also reduced SARS-CoV-2 spike S1-induced activation of NF-κB and the expression of IL-6, IL-1β and TNFα in human A549 lung cells. Moreover, oral treatment with eugenol reduced lung inflammation, decreased fever, improved heart function, and enhanced locomotor activities in SARS-CoV-2 spike S1-intoxicated mice. Therefore, selective targeting of SARS-CoV-2 spike S1, but not ACE2, by eugenol may be beneficial for COVID-19 treatment.
登录
查看更多内容
DOI:
10.3390/molecules17066290
发表时间:
2012-05-25
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
作者:
Jaganathan SK;Supriyanto E
通讯作者:
Supriyanto E
影响因子:
6.2
作者:
Jana, Arundhati;Modi, Khushbu K.;Roy, Avik;Anderson, John A.;van Breemen, Richard B.;Pahan, Kalipada
通讯作者:
Pahan, Kalipada
DOI:
10.1007/s11481-020-09979-8
发表时间:
2021-03
期刊:
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
影响因子:
--
作者:
Paidi RK;Jana M;Mishra RK;Dutta D;Raha S;Pahan K
通讯作者:
Pahan K
DOI:
10.1038/nrmicro2090
发表时间:
2009-03
期刊:
Nature reviews. Microbiology
影响因子:
--
作者:
通讯作者:
--
DOI:
10.1038/s41577-020-00432-8
发表时间:
2020-10-01
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
Pia, Luisanna
通讯作者:
Pia, Luisanna